117 related articles for article (PubMed ID: 6311811)
1. In vitro conversion of proapoprotein A-I to apoprotein A-I. Partial characterization of an extracellular enzyme activity.
Edelstein C; Gordon JI; Toscas K; Sims HF; Strauss AW; Scanu AM
J Biol Chem; 1983 Oct; 258(19):11430-3. PubMed ID: 6311811
[TBL] [Abstract][Full Text] [Related]
2. Tangier disease. In vitro conversion of proapo-A-ITangier to mature APO-A-ITangier.
Bojanovski D; Gregg RE; Brewer HB
J Biol Chem; 1984 May; 259(10):6049-51. PubMed ID: 6725246
[TBL] [Abstract][Full Text] [Related]
3. In vitro studies on origin and site of action of enzyme activity responsible for conversion of human proapoprotein A-I into apoprotein A-I.
Kooistra T; van Hinsbergh V; Havekes L; Kempen HJ
FEBS Lett; 1984 May; 170(1):109-13. PubMed ID: 6327370
[TBL] [Abstract][Full Text] [Related]
4. Decreased proapolipoprotein A-I processing in liver disease: evidence for hepatic participation in proapolipoprotein A-I conversion.
Isobe H; Sakai H; Satoh M; Sakamoto S; Koga S; Nawata H
Clin Chim Acta; 1990 Aug; 189(3):303-11. PubMed ID: 2121392
[TBL] [Abstract][Full Text] [Related]
5. Human proapolipoprotein A-II is cleaved following secretion from Hep G2 cells by a thiol protease.
Gordon JI; Sims HF; Edelstein C; Scanu AM; Strauss AW
J Biol Chem; 1984 Dec; 259(24):15556-63. PubMed ID: 6096378
[TBL] [Abstract][Full Text] [Related]
6. Rat liver and small intestine produce proapolipoprotein A-I which is slowly processed to apolipoprotein A-I in the circulation.
Sliwkowski MB; Windmueller HG
J Biol Chem; 1984 May; 259(10):6459-65. PubMed ID: 6427215
[TBL] [Abstract][Full Text] [Related]
7. Increased proportion of proapolipoprotein A-I in HDL from patients with liver cirrhosis and hepatitis.
Matsuura T; Koga S; Ibayashi H
Gastroenterol Jpn; 1988 Aug; 23(4):394-400. PubMed ID: 2846400
[TBL] [Abstract][Full Text] [Related]
8. In vivo conversion of recombinant human proapolipoprotein AI (rh-Met-proapo AI) to apolipoprotein AI in rabbits.
Saku K; Liu R; Ohkubo K; Bai H; Hirata K; Yamamoto K; Morimoto Y; Yamada K; Arakawa K
Biochim Biophys Acta; 1993 Apr; 1167(3):257-63. PubMed ID: 8481386
[TBL] [Abstract][Full Text] [Related]
9. Increase of plasma proapolipoprotein A-I in patients with liver cirrhosis and its relationship to circulating high-density lipoproteins 2 and 3.
Suehiro T; Yamamoto M; Yoshida K; Ohno F
Clin Chem; 1993 Jan; 39(1):60-5. PubMed ID: 8419059
[TBL] [Abstract][Full Text] [Related]
10. Regulation of apoprotein synthesis and secretion in the human hepatoma Hep G2. The effect of exogenous lipoprotein.
Craig WY; Nutik R; Cooper AD
J Biol Chem; 1988 Sep; 263(27):13880-90. PubMed ID: 2843542
[TBL] [Abstract][Full Text] [Related]
11. Human apolipoprotein A-I. Post-translational modification by fatty acid acylation.
Hoeg JM; Meng MS; Ronan R; Fairwell T; Brewer HB
J Biol Chem; 1986 Mar; 261(9):3911-4. PubMed ID: 3005308
[TBL] [Abstract][Full Text] [Related]
12. Extracellular processing of proapolipoprotein A-II in Hep G2 cell cultures is mediated by a 54-kDa protease immunologically related to cathepsin B.
Gordon JI; Sims HF; Edelstein C; Scanu AM; Strauss AW
J Biol Chem; 1985 Nov; 260(27):14824-31. PubMed ID: 2414299
[TBL] [Abstract][Full Text] [Related]
13. Isoforms of apolipoprotein A-II in human plasma and thoracic duct lymph. Identification of proapolipoprotein A-II and sialic acid-containing isoforms.
Lackner KJ; Edge SB; Gregg RE; Hoeg JM; Brewer HB
J Biol Chem; 1985 Jan; 260(2):703-6. PubMed ID: 2981844
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the metabolic behavior of rat apolipoproteins A-I and A-IV, isolated from both lymph chylomicrons and serum high density lipoproteins.
Dallinga-Thie GM; van't Hooft FM; van Tol A
Int J Biochem; 1986; 18(4):383-8. PubMed ID: 3086149
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of human preproapolipoprotein A-I. A proposed defect in the conversion of pro A-I to A-I in Tangier's disease.
Gordon JI; Sims HF; Lentz SR; Edelstein C; Scanu AM; Strauss AW
J Biol Chem; 1983 Mar; 258(6):4037-44. PubMed ID: 6300070
[TBL] [Abstract][Full Text] [Related]
16. Comparative in vitro study of the pro-apolipoprotein A-I to apolipoprotein A-I converting activity between normal and Tangier plasma.
Edelstein C; Gordon JI; Vergani CA; Catapano AL; Pietrini V; Scanu AM
J Clin Invest; 1984 Sep; 74(3):1098-103. PubMed ID: 6432845
[TBL] [Abstract][Full Text] [Related]
17. Demonstration that the enzyme that converts precursor of apolipoprotein A-I to apolipoprotein A-I is secreted by the hepatocarcinoma cell line Hep G2.
Edelstein C; Kaiser M; Piras G; Scanu AM
Arch Biochem Biophys; 1988 Nov; 267(1):23-30. PubMed ID: 2848450
[TBL] [Abstract][Full Text] [Related]
18. A serum proteinase converts proapolipoprotein AI secreted by rat hepatocytes to the mature apolipoprotein.
Stoffel W; Knyrim K; Bode C
Hoppe Seylers Z Physiol Chem; 1983 Nov; 364(11):1631-40. PubMed ID: 6420309
[TBL] [Abstract][Full Text] [Related]
19. Novel apoprotein A-I-containing lipoprotein produced by a human hepatoma-derived cell line HuH-7.
Yamamoto T; Suda M; Moriwaki Y; Takahashi S; Higashino K
Biochim Biophys Acta; 1990 Oct; 1047(1):49-56. PubMed ID: 2174265
[TBL] [Abstract][Full Text] [Related]
20. Tangier disease: defective recombination of a specific Tangier apolipoprotein A-I isoform (pro-apo A-i) with high density lipoproteins.
Schmitz G; Assmann G; Rall SC; Mahley RW
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6081-5. PubMed ID: 6412234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
